SAC Capital

Broker's Calls

SAC Capital initiates 'hold' on ParkwayLife REIT with TP of $4.69

While SAC Capital sees several positives to the REIT, its target price is capped by a lack of near-term catalysts.
SAC Capital upgrades UMS Holdings to ‘buy’ upon positive 1QFY2022 results - THE EDGE SINGAPORE

Broker's Calls

SAC Capital upgrades UMS Holdings to ‘buy’ upon positive 1QFY2022 results

UMS’s net profit for the 1QFY2022 increased by 26% y-o-y to $19.4 million.

Broker's Calls

Broker's Digest: CDL, BRC Asia, ST Engineering

See what the analysts have to say on these counters.

Broker's Calls

'Hold' BRC Asia on construction rebound, easing steel prices: SAC Capital

“We are, however, more concerned about the impact of a price decline.”

Broker's Calls

Analysts positive on Hyphens Pharma as 1Q results beat expectations

CGS-CIMB gives a target price of 36 cents, while SAC Capital hands Hyphens a 40 cents target price.
SAC optimistic on Avi-Tech but does not give formal rating  - THE EDGE SINGAPORE

Broker's Calls

SAC optimistic on Avi-Tech but does not give formal rating

SAC notes that Avi-Tech's recovery is tied to the prospects of the automotive semicon sector, which is expected to grow.

Broker's Calls

SAC Capital starts China Shenshan Orchard at 'buy', calls company 'undervalued'

The brokerage has also pegged an estimate of 70 cents on the company.
Analysts positive on Hyphens Pharma with Novem acquisition to boost growth - THE EDGE SINGAPORE

Broker's Calls

Analysts positive on Hyphens Pharma with Novem acquisition to boost growth

Analysts positive on Hyphens Pharma with Novem acquisition to boost growth

Broker's Calls

SAC Capital says tax charge for UMS will affect future earnings, awaits appeal result

Despite higher revenue for FY2021, UMS got hit with a surprise tax charge in Malaysia, leading SAC to lower its target price.

Equity raising

Adventus Holdings to raise $3.1 million via placement

Adventus wants to improve its working capital
×